ACET
Price
$0.92
Change
+$0.03 (+3.37%)
Updated
Dec 24, 02:00 PM (EDT)
78 days until earnings call
ZTS
Price
$164.66
Change
+$0.38 (+0.23%)
Updated
Dec 24, 01:59 PM (EDT)
56 days until earnings call
Ad is loading...

ACET vs ZTS

Header iconACET vs ZTS Comparison
Open Charts ACET vs ZTSBanner chart's image
Adicet Bio
Price$0.92
Change+$0.03 (+3.37%)
Volume$902
CapitalizationN/A
ZOETIS
Price$164.66
Change+$0.38 (+0.23%)
Volume$4.02K
CapitalizationN/A
ACET vs ZTS Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. ZTS commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and ZTS is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (ACET: $0.89 vs. ZTS: $164.28)
Brand notoriety: ACET: Not notable vs. ZTS: Notable
ACET represents the Biotechnology, while ZTS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 67% vs. ZTS: 90%
Market capitalization -- ACET: $73.64M vs. ZTS: $77.48B
ACET [@Biotechnology] is valued at $73.64M. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than ACET.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 3 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 3 bullish, 4 bearish.
  • ZTS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -7.16% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -6.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +3.17%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.21%. For the same industry, the average monthly price growth was -0.33%, and the average quarterly price growth was -8.52%.

Reported Earning Dates

ACET is expected to report earnings on Mar 12, 2025.

ZTS is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (-1.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than ACET($73.6M). ZTS YTD gains are higher at: -15.941 vs. ACET (-52.714). ZTS has higher annual earnings (EBITDA): 3.67B vs. ACET (-111.35M). ZTS has more cash in the bank: 2.04B vs. ACET (202M). ACET has less debt than ZTS: ACET (18.2M) vs ZTS (6.76B). ZTS has higher revenues than ACET: ZTS (8.54B) vs ACET (0).
ACETZTSACET / ZTS
Capitalization73.6M77.5B0%
EBITDA-111.35M3.67B-3%
Gain YTD-52.714-15.941331%
P/E RatioN/A32.94-
Revenue08.54B-
Total Cash202M2.04B10%
Total Debt18.2M6.76B0%
FUNDAMENTALS RATINGS
ACET vs ZTS: Fundamental Ratings
ACET
ZTS
OUTLOOK RATING
1..100
5878
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
9721
PRICE GROWTH RATING
1..100
8762
P/E GROWTH RATING
1..100
2276
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (33) in the Medical Distributors industry is in the same range as ZTS (35) in the Pharmaceuticals Generic industry. This means that ACET’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (58) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ACET (100) in the Medical Distributors industry. This means that ZTS’s stock grew somewhat faster than ACET’s over the last 12 months.

ZTS's SMR Rating (21) in the Pharmaceuticals Generic industry is significantly better than the same rating for ACET (97) in the Medical Distributors industry. This means that ZTS’s stock grew significantly faster than ACET’s over the last 12 months.

ZTS's Price Growth Rating (62) in the Pharmaceuticals Generic industry is in the same range as ACET (87) in the Medical Distributors industry. This means that ZTS’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (22) in the Medical Distributors industry is somewhat better than the same rating for ZTS (76) in the Pharmaceuticals Generic industry. This means that ACET’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETZTS
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 13 days ago
61%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
54%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGNX36.150.38
+1.06%
Cognex Corp
MS124.451.01
+0.82%
Morgan Stanley
PGC32.53-0.42
-1.27%
Peapack-Gladstone Financial Corp
PED0.73-0.01
-1.34%
PEDEVCO Corp
SJW49.07-1.13
-2.25%
SJW Group

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-1.79%
OGI - ACET
41%
Loosely correlated
+1.28%
DVAX - ACET
39%
Loosely correlated
+0.86%
KYMR - ACET
38%
Loosely correlated
+0.32%
CRON - ACET
36%
Loosely correlated
+3.08%
PRTA - ACET
36%
Loosely correlated
+0.72%
More